Characterization of high-altitude pulmonary hypertension in the Kyrgyz: Association with angiotensin-converting enzyme genotype

American Journal of Respiratory and Critical Care Medicine

Volumn 166, Issue 10, 2002, Pages 1396-1402

  Aldashev, Almaz A ^a,b,c,d   Sarybaev, Akpay S ^a,b,c   Sydykov, Akyl S ^a,b,c   Kalmyrzaev, Bolot B ^a,b,c   Kim, Elena V ^a,b,c   Mamanova, Lira B ^a,b,c   Maripov, Rashid ^a,b,c   Kojonazarov, Baktybek K ^a,b,c   Mirrakhimov, Mirsaid M ^a,b,c   Wilkins, Martin R ^a,b,c   Morrell, Nicholas W ^a,b,c,e  

^a National Center for Cardiology and Internal Medicine   (Kyrgyzstan)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d National Center of Cardiology and Internal Medicine   (Kyrgyzstan)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Altitude; Angiotensin converting enzyme; Hypoxia; Pulmonary hypertension

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; ALTITUDE; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENETIC RISK; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG BIOPSY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RISK ASSESSMENT; RISK FACTOR;

EID: 0037111313     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.200204-345OC     Document Type: Article

References (43)

1. von Euler US, Liljestrand G. Observations on the pulmonary aterial blood pressure in the cat. Acta Physiol Scand 1946;12:301-320.
2. Meyrick B, Reid L. Hypoxia-induced structural changes in the media and adventitia of the rat hilar pulmonary artery and their regression. Am J Pathol 1980;100:151-178.
3. Hislop A, Reid L. New findings in pulmonary arteries of rats with hypoxia-induced pulmonary hypertension. Br J Exp Pathol 1976;57:542-554.
4. Mirrakhimov M, Winslow R. The cardiovascular system at high altitude. In: Fregley M, Blatteal C, editors. Environmental Physiology. Oxford: Oxford University Press; 1996. p. 1241-1258.
5. Wensel R, Opitz CF, Ewert R, Bruch L, Kleber FX. Effects of iloprost inhalation on exercise capacity and ventilatory efficiency in patients with primary pulmonary hypertension. Circulation 1999;101:2388-2392.
6. Palevsky HI, Fishman AP. Chronic cor pulmonale: Etiology and management. JAMA 1990;263:2347-2353.
7. Weir EK, Tucker A, Reeves JT, Will DH, Grover RF. The genetic factor influencing pulmonary hypertension in cattle at high altitude. Cardiovasc Res 1974;8:745-749.
8. Aguirre JI, Morrell NW, Long L, Clift P, Upton PD, Polak JM, Wilkins MR. Vascular remodeling and ET-1 expression in rat strains with different responses to chronic hypoxia. Am J Physiol 2000;278:L981-L987.
9. Salameh G, Karamsetty R, Warburton RR, Klinger JR, Ou LC, Hill NS. Differences in acute hypoxic pulmonary vasoresponsiveness between rat strains: Role of endothelium. Am J Physiol 1999;87:356-362.
10. Zhao L, Sebkhi A, Nunez DJ, Long L, Haley CS, Szpirer J, Williams AJ, Wilkins MR. Right ventricular hypertrophy secondary to pulmonary hypertension linked to rat chromosome 17: Evaluation of cardiac ryanodine Ryr2 receptor as a candidate. Circulation 2001;103:442-447.
11. Westcott RN, Fowler NO, Scott RC, Hauenstein VD, McGuire J. Anoxia and human pulmonary vascular resistance. J Clin Invest 1951;30:457-470.
12. Vogel HJK, Weaver WF, Rose LD. Pulmonary hypertension on exertion in normal man living at 10,150 feet (Leadville, Colorado). In: Grover RF, editor. Normal and Abnormal Pulmonary Circulation. Basel, Switzerland: S. Karger; 1963. p. 289-291.
13. Groves BM, Droma T, Sutton JR, McCullough RG, McCullough RE, Zhuang J, Rapmund G, Sun S, Janes C, Moore LG. Minimal hypoxic pulmonary hypertension in normal Tibetans at 3,658m. J Appl Physiol 1993;74:312-318.
14. Morrell NW, Sarybaev AS, Alikhan A, Mirrakhimov MM, Aldashev A. ACE genotype and risk of high altitude pulmonary hypertension in Kyrghyz highlanders. Lancet 1999;353:814.
15. Villard E, Soubrier F. Molecular biology and genetics of the angiotensin-I-converting enzyme: Potential implications in cardiovascular diseases. Cardiovasc Res 1996;32:999-1007.
16. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990;86:1343-1346.
17. Chou T-C, Knilans TK. Right ventricular hypertrophy. In: Electrocardiography in Clinical Practice, 4th Ed. Philadelphia: W.B. Saunders; 1996. p. 54-69.
18. Heath D. Pulmonary vascular disease. In: Hasleton PS, editor. Spencer's Pathology of the Lung, 5th Ed. London: McGraw-Hill; 1996. p. 649-693.
19. Marre M, Jeunemaitre X, Gallois Y, Rodier M, Chatellier G, Sert C, Dusselier L, Kahal Z, Chaillous L, Halimi S, et al. Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes. Genetique de la Nephropathie Diabetique (GENEDIAB) Study Group. J Clin Invest 1997;99:1585-1595.
20. Danilov S, Savoie F, Lenoir B, Jeunemaitre X, Azizi M, Tarnow L, Alhenc-Gelas F. Development of enzyme-linked immunoassays for human angiotensin converting enzyme suitable for large-scale studies. J Hypertens 1996;14:719-727.
21. Morrell NW, Atochina EN, Morris KG, Danilov SG, Stenmark KR. Angiotensin converting enzyme expression is increased in small pulmonary arteries of rats with hypoxia-induced pulmonary hypertension. J Clin Invest 1995;96:1823-1833.
22. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, Soubrier F. Evidence from combined segregation and linkage analysis that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992;51:197-205.
23. Rabinovitch M, Gamble WJ, Miettinen OS, Reid L. Age and sex influence on pulmonary hypertension of chronic hypoxia and on recovery. Am J Physiol 1981;240:H62-H72.
24. Weitzenblum E, Mammosser M, Ehrhart M. Evolution and prognosis of pulmonary hypertension in chronic obstructive pulmonary disease. Herz 1986;11:147-154.
25. Reeves JT, Durmowicz AG. High altitude and the pulmonary circulation. In: Peacock AJ, editor. Pulmonary Circulation: A Handbook for Physicians. London: Chapman & Hall; 1996. p. 262-272.
26. Morrell NW, Nijran KS, Biggs T, Seed WA. Magnitude and time course of acute hypoxic pulmonary vasoconstriction in man. Respir Physiol 1995;100:271-281.
27. Sui GJ, Liu YH, Cheng XS, Anand IS, Harris E, Harris P, Heath D. Subacute infantile mountain sickness. J Pathol 1988;155:161-170.
28. Niermeyer S, Yang P, Shanmina, Drolkar, Zhuang J, Moore LG. Arterial oxygen saturation in Tibetan and Han infants born in Lhasa, Tibet. N Engl J Med 1995;333:1248-1252.
29. Morrell NW, Morris KG, Stenmark KR. Role of angiotensin converting enzyme and angiotensin II in development of hypoxic pulmonary hypertension. Am J Physiol 1995;269:H1186-H1194.
30. Zhao L, Al-Tubuly R, Sebkhi A, Owji AA, Nunez D JR, Wilkins MR. Angiotensin II receptor expression and inhibition in the chronically hypoxic rat lung. Br J Pharmacol 1996;119:1217-1222.
31. Nong Z, Stassen JM, Moons L, Collen D, Janssens S. Inhibition of tissue angiotensin converting enzyme with quinapril reduces hypoxic pulmonary hypertension and pulmonary, vascular remodelling. Circulation 1996;94:1941-1947.
32. van Suylen RJ, Smits JFM, Daemen MJAP. Pulmonary artery remodeling differs in hypoxia- and monocrotaline-induced pulmonary hypertension. Am J Respir Crit Care Med 1998;157:1423-1428.
33. van Suylen RJ, Aartsen WM, Smits JFM, Daemen MJAP. Dissociation of pulmonary vascular remodeling and right ventricular pressure in tissue angiotensin-converting enzyme-deficient mice under conditions of chronic alveolar hypoxia. Am J Respir Crit Care Med 2001;163:1241-1245.
34. Tsutaya S, Kitaya H, Saito Y, Nakuta S, Takamatsu H, Yasujima M. Angiotensin converting enzyme gene polymorphism and its enzyme activity in serum in young Japanese females. Tohoku J Exp Med 1997; 182:151-155.
35. Sagnella GA, Rothwell MJ, Onipinla AK, Wicks PD, Cook DG. A population study of ethnic variations in the angiotensin converting enzyme I/D polymorphism: Relationships with gender, hypertension and impaired glucose metabolism. J Hypertens 1999;17:657-664.
36. 1 receptors. Am J Physiol 1999;277:L440-L448.
37. Mombouli JV, Vanhoutte PM. Endothelial dysfunction: From physiology to therapy. J Mol Cell Cardiol 1999;31:61-74.
38. Montgomery H, Humphries S, Danilov S. Is genotype or phenotype the better tool for investigating the role of ACE in human cardiovascular disease. Eur Heart J 2002;1083-1086.
39. Myerson S, Hemingway H, Budget R, Martin J, Humphries SE, Montgomery HE. Human angiotensin-I-converting enzyme gene and endurance performance. J Appl Physiol 1999;87:1313-1316.
40. Montgomery HE, Marshall R, Hemingway H, Myerson S, Clarkson P, Dollery C, Hayward M, Holliman DE, Jubb M, World M, et al. Human gene for physical performance. Nature 1998;393:221-222.
41. Groves BM, Reeves JT, Sutton JR, Wagner PD, Cymerman A, Malconian MK, Rock PB, Young PM, Houston CS. Operation Everest II: Elevated high-altitude pulmonary resistance unresponsive to oxygen. J Appl Physiol 1987;63:521-530.
42. van Suylen RJ, Wouters E, Pennings H, Cheriex E, van Pol P, Ambergen A, Vermelis AM, Daemen MJAP. The DD genotype of the angiotensin converting enzyme gene is negatively associated with right ventricular hypertrophy in male patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;159:1791-1795.
43. Abraham WT, Raynolds MV, Gottschall B, Badesch DB, Wynne KM, Groves BM, Lowes BD, Bristow MR, Perryman MB, Voelkel NF. Importance of angiotensin-converting enzyme in pulmonary hypertension. Cardiology 1995;86:9-15.